Biography
Thierry M. Jahan, M.D. is a renowned medical oncologist who specializes in the treatment of thoracic malignancies such as lung cancer and mesothelioma, and soft tissue sarcomas. Dr. Jahan received his M.D. from George Washington University, thereafter completing his residency and internal medicine residency at Cedars Sinai Medical Center in Los Angeles. He later was a clinical fellows in hematology and oncology at UCSF, eventually joining the UCSF faculty. Dr. Jahan co-founded the Thoracic Oncology Program with David Jablons, M.D.
In addition to his keen clinical insight, Dr. Jahan is known by patients, their families and fellow clinicians for his sense of empathy and compassion. His steadfast commitment to eliminating the scourge of lung cancer is evidenced by the pins and ribbons adorning his white coat, a clear message of hope to patients.
In 2016, Dr. Jahan was inducted into the Council of Master Clinicians by the UCSF Department of Medicine, a select group of outstanding physicians with exceptional knowledge, superior teaching and communication skills, and the ability to provide compassionate, appropriate, effective, and high-quality patient care.
Dr. Jahan has been the recipient of numerous awards including the Medical House Staff Outstanding Teacher Award and Friend of the Palliative Care Service Award. He is also a member of numerous professional organizations, including the American College of Physicians, American Society of Clinical Oncology (ASCO), and International Association for the Study of Lung Cancer (IASLC) and the Association of Northern California Oncologists.
Dr. Jahan has authored or co-authored numerous peer-reviewed articles, book chapters and research abstracts and lectured nationally and internationally on lung cancer and mesothelioma. Numerous major media outlets including The San Francisco Chronicle, Time Magazine and KPIX San Francisco have sought out his opinions and observations on treatments and advances in lung cancer.
Education
Institution | Degree | Dept or School | End Date |
---|---|---|---|
University of California, San Francisco | Fellowship | Hematology/Oncology | 06/1994 |
University of California, Los Angeles | Kennamer Fellowship | Internal Medicine | 06/1991 |
University of California, Los Angeles | Residency | Internal Medicine | 06/1990 |
George Washington University School of Medicine and Health Sciences | MD | 06/1987 | |
Columbia University | BA | Psychology | 05/1983 |
Clinical Trials
- Related Conditions: Mesothelioma, Lung Cancer, Lung Tumor| Start Date: | End Date:
In the News
Publications
- Aggressive and minimally invasive surgery for pulmonary metastasis of sarcoma.| | PubMed
- A novel use of foley catheters to prevent injury to the pelvic viscera during stereotactic radiosurgery for undifferentiated pleomorphic sarcoma of the sacrum.| | PubMed
- VATS lobectomy facilitates the delivery of adjuvant docetaxel-carboplatin chemotherapy in patients with non-small cell lung cancer.| | PubMed
- Desmoplastic fibroma of the spine causing severe mediastinal compression and brachial plexus encasement: report of 2 cases.| | PubMed
- Non-small cell lung cancer, version 2.2013.| | PubMed
- Thymomas and thymic carcinomas: Clinical Practice Guidelines in Oncology.| | PubMed
- Small cell lung cancer.| | PubMed
- Non-small cell lung cancer.| | PubMed
- Determination of cutpoints for low and high number of symptoms in patients with advanced cancer.| | PubMed
- A phase II study of enzastaurin in combination with erlotinib in patients with previously treated advanced non-small cell lung cancer.| | PubMed